Multiple Myeloma Treatment in India: What Anti-CD38 Antibody Trial Data and Labels Report
For hospital pharmacy committees, oncology and haematology units, clinics and pharmacies, anti-CD38 monoclonal antibodies are among the most frequently cited biologics in multiple myeloma. This article reports what prescribing information and published trials say about this class, written for institutional buyers and clinicians. It is informational reporting, not clinical guidance. What the Label Describes The […]
